221 related articles for article (PubMed ID: 17525716)
1. Hypothesis--haptoglobin genotype and diabetic nephropathy.
Nakhoul FM; Miller-Lotan R; Awaad H; Asleh R; Levy AP
Nat Clin Pract Nephrol; 2007 Jun; 3(6):339-44. PubMed ID: 17525716
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomic effect of vitamin E on kidney structure and function in transgenic mice with the haptoglobin 2-2 genotype and diabetes mellitus.
Nakhoul FM; Miller-Lotan R; Awad H; Asleh R; Jad K; Nakhoul N; Asaf R; Abu-Saleh N; Levy AP
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F830-8. PubMed ID: 19176700
[TBL] [Abstract][Full Text] [Related]
3. Application of pharmacogenomics in the prevention of diabetic cardiovascular disease: mechanistic basis and clinical evidence for utilization of the haptoglobin genotype in determining benefit from antioxidant therapy.
Levy AP
Pharmacol Ther; 2006 Nov; 112(2):501-12. PubMed ID: 16854468
[TBL] [Abstract][Full Text] [Related]
4. Increased renal hypertrophy in diabetic mice genetically modified at the haptoglobin locus.
Miller-Lotan R; Herskowitz Y; Kalet-Litman S; Nakhoul F; Aronson D; Zoabi R; Asaf R; Ben-Izhak O; Sabo E; Lim SK; Baumann H; Berger FG; Levy AP
Diabetes Metab Res Rev; 2005; 21(4):332-7. PubMed ID: 15852445
[TBL] [Abstract][Full Text] [Related]
5. Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial.
Milman U; Blum S; Shapira C; Aronson D; Miller-Lotan R; Anbinder Y; Alshiek J; Bennett L; Kostenko M; Landau M; Keidar S; Levy Y; Khemlin A; Radan A; Levy AP
Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):341-7. PubMed ID: 18032779
[TBL] [Abstract][Full Text] [Related]
6. In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular disease.
Asleh R; Levy AP
Vasc Health Risk Manag; 2005; 1(1):19-28. PubMed ID: 17319095
[TBL] [Abstract][Full Text] [Related]
7. Haptoglobin genotype determines myocardial infarct size in diabetic mice.
Blum S; Asaf R; Guetta J; Miller-Lotan R; Asleh R; Kremer R; Levy NS; Berger FG; Aronson D; Fu X; Zhang R; Hazen SL; Levy AP
J Am Coll Cardiol; 2007 Jan; 49(1):82-7. PubMed ID: 17207726
[TBL] [Abstract][Full Text] [Related]
8. Haptoglobin polymorphism and diabetic retinopathy in Brazilian patients.
Wobeto VP; Rosim ET; Melo MB; Calliari LE; Sonati Mde F
Diabetes Res Clin Pract; 2007 Sep; 77(3):385-8. PubMed ID: 17275123
[TBL] [Abstract][Full Text] [Related]
9. [HAPTOGLOBIN POLYMORPHISM AS AN INDEPENDENT PREDICTOR OF DIABETIC NEPHROPATHY AND RETINOPATHY].
Dahan I; Thauho N; Nakhoul F; Nakhoul N; Jabaly H; Farber E
Harefuah; 2016 Jul; 155(7):439-442. PubMed ID: 28514126
[TBL] [Abstract][Full Text] [Related]
10. Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease.
Asleh R; Marsh S; Shilkrut M; Binah O; Guetta J; Lejbkowicz F; Enav B; Shehadeh N; Kanter Y; Lache O; Cohen O; Levy NS; Levy AP
Circ Res; 2003 Jun; 92(11):1193-200. PubMed ID: 12750308
[TBL] [Abstract][Full Text] [Related]
11. Is there a relationship between genetically determined haptoglobin phenotype and insulin-dependent diabetes mellitus (IDDM)?
Ratzmann KP; Strese J; Keilacker H; Giebelmann R; Scheibe F; Witt S
Exp Clin Endocrinol; 1984 Apr; 83(2):207-15. PubMed ID: 6539222
[TBL] [Abstract][Full Text] [Related]
12. The protean role of haptoglobin and haptoglobin genotypes on vascular complications in diabetes mellitus.
Dalan R; Liuh Ling G
Eur J Prev Cardiol; 2018 Sep; 25(14):1502-1519. PubMed ID: 29799294
[TBL] [Abstract][Full Text] [Related]
13. Haptoglobin phenotype and vascular complications in patients with diabetes.
Levy AP; Roguin A; Hochberg I; Herer P; Marsh S; Nakhoul FM; Skorecki K
N Engl J Med; 2000 Sep; 343(13):969-70. PubMed ID: 11012324
[No Abstract] [Full Text] [Related]
14. Relation of haptoglobin phenotype to early vascular changes in patients with diabetes mellitus.
Shor M; Boaz M; Gavish D; Wainshtein J; Matas Z; Shargorodsky M
Am J Cardiol; 2007 Dec; 100(12):1767-70. PubMed ID: 18082523
[TBL] [Abstract][Full Text] [Related]
15. The Haptoglobin genotype predicts cardio-renal mortality in type 1 diabetes.
Costacou T; Orchard TJ
J Diabetes Complications; 2016 Mar; 30(2):221-6. PubMed ID: 26684170
[TBL] [Abstract][Full Text] [Related]
16. Does haptoglobin genotype affect early onset of diabetic retinopathy in patients with type 2 diabetes?
Goldenberg-Cohen N; Gabbay M; Dratviman-Storobinsky O; Reich E; Axer-Siegel R; Weinberger D; Gabbay U
Retina; 2011 Sep; 31(8):1574-80. PubMed ID: 21555971
[TBL] [Abstract][Full Text] [Related]
17. MTHFR gene polymorphism is susceptible to diabetic retinopathy but not to diabetic nephropathy in Japanese type 2 diabetic patients.
Maeda M; Yamamoto I; Fukuda M; Motomura T; Nishida M; Nonen S; Fujio Y; Kasayama S; Azuma J
J Diabetes Complications; 2008; 22(2):119-25. PubMed ID: 18280442
[TBL] [Abstract][Full Text] [Related]
18. Haptoglobin genotype is a determinant of iron, lipid peroxidation, and macrophage accumulation in the atherosclerotic plaque.
Levy AP; Levy JE; Kalet-Litman S; Miller-Lotan R; Levy NS; Asaf R; Guetta J; Yang C; Purushothaman KR; Fuster V; Moreno PR
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):134-40. PubMed ID: 17068284
[TBL] [Abstract][Full Text] [Related]
19. Retinal capillary basement membrane thickness in diabetic mice genetically modified at the haptoglobin locus.
Miller-Lotan R; Miller B; Nakhoul F; Aronson D; Asaf R; Levy AP
Diabetes Metab Res Rev; 2007 Feb; 23(2):152-6. PubMed ID: 16742000
[TBL] [Abstract][Full Text] [Related]
20. Genotype-dependent impairment of hemoglobin clearance increases oxidative and inflammatory response in human diabetic atherosclerosis.
Purushothaman M; Krishnan P; Purushothaman KR; Baber U; Tarricone A; Perez JS; Wiley J; Kini A; Sharma SK; Fuster V; Moreno PR
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2769-75. PubMed ID: 22982461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
